✦ LIBER ✦

The Editor’s Roundtable: Cyclooxygenase-2 Inhibitors and Cardiovascular Risk

✍ Scribed by Robert S. Bresalier; Vincent E. Friedewald Jr; Robert E. Rakel; William C. Roberts; Gary W. Williams

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Editor's Roundtable: Nonsteroidal An

✍ Vincent E. Friedewald Jr.; Joel S. Bennett; Milton Packer; William C. Roberts; G 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 123 KB

The Editor's Roundtable: Anemia and Card

✍ Vincent E. Friedewald; Michael Emmett; Peter McCullough; Clyde W. Yancy; William 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 137 KB

The Editor's Roundtable: Lipid Managemen

✍ Vincent E. Friedewald Jr.; Christie M. Ballantyne; Michael H. Davidson; John R. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 89 KB

The risk of cardiovascular thrombotic ev

✍ Strand, Vibeke ;Hochberg, Marc C. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Selective cyclooxygenase-2 (COX-2) inhib

✍ Debabrata Mukherjee 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Selective cyclooxygenase 2 inhibitors an

✍ Daniel H. Solomon 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB